Indications and Purposes
| 1 Indications And Usage Sevenfact [Coagulation Factor Viia (Recombinant)-Jncw] Is Indicated For The Treatment And Control Of Bleeding Episodes Occurring In Adults And Adolescents (12 Years Of Age And Older) With Hemophilia A Or B With Inhibitors. Limitation Of Use: Sevenfact Is Not Indicated For The Treatment Of Patients With Congenital Factor Vii Deficiency. Sevenfact [Coagulation Factor Viia (Recombinant)-Jncw] Is A Coagulation Factor Viia Concentrate Indicated For The Treatment And Control Of Bleeding Episodes Occurring In Adults And Adolescents (12 Years Of Age And Older) With Hemophilia A Or B With Inhibitors ( 1 ). Limitation Of Use: Sevenfact Is Not Indicated For Treatment Of Congenital Factor Vii Deficiency. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Coagulation Factor Viia Recombinant Human |